Centessa Pharmaceuticals PLC
NASDAQ:CNTA

Watchlist Manager
Centessa Pharmaceuticals PLC Logo
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Watchlist
Price: 16.88 USD -1.63%
Market Cap: 2.2B USD
Have any thoughts about
Centessa Pharmaceuticals PLC?
Write Note

Intrinsic Value

The intrinsic value of one CNTA stock under the Base Case scenario is 0.46 USD. Compared to the current market price of 16.88 USD, Centessa Pharmaceuticals PLC is Overvalued by 97%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CNTA Intrinsic Value
0.46 USD
Overvaluation 97%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Centessa Pharmaceuticals PLC

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
CNTA
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for CNTA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about CNTA?
Bearish
Neutral
Bullish

Fundamental Analysis

16.88 USD
-1.63%
-1.63%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Centessa Pharmaceuticals PLC
UK
Biotechnology
Market Cap
2.2B USD
IPO
May 28, 2021
Employees
90
United Kingdom
Market Cap
2.2B USD
Industry
Biotechnology
IPO
May 28, 2021
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Centessa Pharmaceuticals PLC

Provide an overview of the primary business activities
of Centessa Pharmaceuticals PLC.

What unique competitive advantages
does Centessa Pharmaceuticals PLC hold over its rivals?

What risks and challenges
does Centessa Pharmaceuticals PLC face in the near future?

Has there been any significant insider trading activity
in Centessa Pharmaceuticals PLC recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Centessa Pharmaceuticals PLC.

Provide P/S
for Centessa Pharmaceuticals PLC.

Provide P/E
for Centessa Pharmaceuticals PLC.

Provide P/OCF
for Centessa Pharmaceuticals PLC.

Provide P/FCFE
for Centessa Pharmaceuticals PLC.

Provide P/B
for Centessa Pharmaceuticals PLC.

Provide EV/S
for Centessa Pharmaceuticals PLC.

Provide EV/GP
for Centessa Pharmaceuticals PLC.

Provide EV/EBITDA
for Centessa Pharmaceuticals PLC.

Provide EV/EBIT
for Centessa Pharmaceuticals PLC.

Provide EV/OCF
for Centessa Pharmaceuticals PLC.

Provide EV/FCFF
for Centessa Pharmaceuticals PLC.

Provide EV/IC
for Centessa Pharmaceuticals PLC.

Show me price targets
for Centessa Pharmaceuticals PLC made by professional analysts.

What are the Revenue projections
for Centessa Pharmaceuticals PLC?

How accurate were the past Revenue estimates
for Centessa Pharmaceuticals PLC?

What are the Net Income projections
for Centessa Pharmaceuticals PLC?

How accurate were the past Net Income estimates
for Centessa Pharmaceuticals PLC?

What are the EPS projections
for Centessa Pharmaceuticals PLC?

How accurate were the past EPS estimates
for Centessa Pharmaceuticals PLC?

What are the EBIT projections
for Centessa Pharmaceuticals PLC?

How accurate were the past EBIT estimates
for Centessa Pharmaceuticals PLC?

Compare the revenue forecasts
for Centessa Pharmaceuticals PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Centessa Pharmaceuticals PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Centessa Pharmaceuticals PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Centessa Pharmaceuticals PLC compared to its peers.

Compare the P/E ratios
of Centessa Pharmaceuticals PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Centessa Pharmaceuticals PLC with its peers.

Analyze the financial leverage
of Centessa Pharmaceuticals PLC compared to its main competitors.

Show all profitability ratios
for Centessa Pharmaceuticals PLC.

Provide ROE
for Centessa Pharmaceuticals PLC.

Provide ROA
for Centessa Pharmaceuticals PLC.

Provide ROIC
for Centessa Pharmaceuticals PLC.

Provide ROCE
for Centessa Pharmaceuticals PLC.

Provide Gross Margin
for Centessa Pharmaceuticals PLC.

Provide Operating Margin
for Centessa Pharmaceuticals PLC.

Provide Net Margin
for Centessa Pharmaceuticals PLC.

Provide FCF Margin
for Centessa Pharmaceuticals PLC.

Show all solvency ratios
for Centessa Pharmaceuticals PLC.

Provide D/E Ratio
for Centessa Pharmaceuticals PLC.

Provide D/A Ratio
for Centessa Pharmaceuticals PLC.

Provide Interest Coverage Ratio
for Centessa Pharmaceuticals PLC.

Provide Altman Z-Score Ratio
for Centessa Pharmaceuticals PLC.

Provide Quick Ratio
for Centessa Pharmaceuticals PLC.

Provide Current Ratio
for Centessa Pharmaceuticals PLC.

Provide Cash Ratio
for Centessa Pharmaceuticals PLC.

What is the historical Revenue growth
over the last 5 years for Centessa Pharmaceuticals PLC?

What is the historical Net Income growth
over the last 5 years for Centessa Pharmaceuticals PLC?

What is the current Free Cash Flow
of Centessa Pharmaceuticals PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Centessa Pharmaceuticals PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Centessa Pharmaceuticals PLC

Current Assets 315.1m
Cash & Short-Term Investments 256.5m
Receivables 39.1m
Other Current Assets 19.4m
Non-Current Assets 45.2m
PP&E 13m
Other Non-Current Assets 32.2m
Current Liabilities 39.4m
Accounts Payable 11.8m
Accrued Liabilities 27.5m
Other Current Liabilities 112k
Non-Current Liabilities 84.6m
Long-Term Debt 75.7m
Other Non-Current Liabilities 8.9m
Efficiency

Earnings Waterfall
Centessa Pharmaceuticals PLC

Revenue
6.9m USD
Operating Expenses
-178.1m USD
Operating Income
-171.3m USD
Other Expenses
20.2m USD
Net Income
-151.1m USD

Free Cash Flow Analysis
Centessa Pharmaceuticals PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CNTA Profitability Score
Profitability Due Diligence

Centessa Pharmaceuticals PLC's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

23/100
Profitability
Score

Centessa Pharmaceuticals PLC's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

CNTA Solvency Score
Solvency Due Diligence

Centessa Pharmaceuticals PLC's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
52/100
Solvency
Score

Centessa Pharmaceuticals PLC's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CNTA Price Targets Summary
Centessa Pharmaceuticals PLC

Wall Street analysts forecast CNTA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CNTA is 29 USD with a low forecast of 24.24 USD and a high forecast of 36.75 USD.

Lowest
Price Target
24.24 USD
44% Upside
Average
Price Target
29 USD
72% Upside
Highest
Price Target
36.75 USD
118% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CNTA?

Click here to dive deeper.

Dividends

Centessa Pharmaceuticals PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for CNTA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CNTA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one CNTA stock?

The intrinsic value of one CNTA stock under the Base Case scenario is 0.46 USD.

Is CNTA stock undervalued or overvalued?

Compared to the current market price of 16.88 USD, Centessa Pharmaceuticals PLC is Overvalued by 97%.

Back to Top